Mon 02/27/2023 18:12 PM
Relevant Items:Preliminary OMCovenant AnalysisHistorical Financials on Aggredium
Transaction Overview
Israel-headquartered pharmaceutical group Teva Pharmaceuticals Industries has launched a $2.06 billion senior notes offering concurrent with a
tender offer to purchase for cash up to $2.25 billion of senior notes, exclusive of accrued and unpaid interest, due from 2023 to 2026.
The issuer said it expects to raise the equivalent of $1.06 billion of euro-denominated notes and $1 billion of...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.